Request Appointment
520 East 70th StreetStarr Pavilion, 3rd FloorNew York, NY 10021
Overview of Dr. Saxena
Dr. Ashish Saxena is an oncologist in New York, NY and is affiliated with New York-Presbyterian Hospital. He received his medical degree from Stony Brook University Health Sciences Center School of Medicine and has been in practice 11 years. He is one of 372 doctors at New York-Presbyterian Hospital who specialize in Oncology. He has more than 40 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterPost-Doctoral Fellowship, 2013 - 2015
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2010 - 2013
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2007 - 2010
Stony Brook University Health Sciences Center School of MedicineClass of 2006
Stony Brook University Graduate SchoolPhD, Genetics, 1999 - 2004
Certifications & Licensure
NY State Medical License 2010 - 2025
Awards, Honors, & Recognition
- Outstanding House Officer in Ambulatory Care Medicine Albert Einstein College of Medicine/Montefiore Medical Center Department of Medicine, 2010
Publications & Presentations
PubMed
- Survival in immune checkpoint inhibitor-treated patients with rheumatoid arthritis and non-small cell lung cancer: an observational cohort study.Deanna P Jannat-Khah, Fenglong Xie, Ashish Saxena, Jeffrey R Curtis, Anne R Bass
Arthritis Care & Research. 2025-04-28 - Error-corrected flow-based sequencing at whole-genome scale and its application to circulating cell-free DNA profiling.Alexandre Pellan Cheng, Adam J Widman, Anushri Arora, Itai Rusinek, Aaron Sossin
Nature Methods. 2025-04-11 - Incidence of checkpoint inhibitor-associated inflammatory arthritis, immunomodulation and mortality in cancer patients on immunotherapy: a retrospective cohort study.Anne R Bass, Fenglong Xie, Deanna Jannat-Khah, Nilasha Ghosh, Karmela K Chan
Rheumatology. 2025-04-01
Journal Articles
- Extracellular Vesicles in DLBCL Provide Abundant Clues to Aberrant Transcriptional Programming and Genomic AlterationsSarah C Rutherford, Ashish Saxena, Rita Shaknovich, Blood
Press Mentions
Minimizing Hair Loss During Chemotherapy: Is It Possible?July 15th, 2019- The Side Effects of Chemotherapy: Here’s What to ExpectJuly 15th, 2019
- What Is “Chemo Brain” + How Long Does It Last?July 15th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
